AzTrials
AzTrials

Accidental HypothermiaIHRNCT06200285

International Registry of Accidental Hypothermia

An observational study of Accidental Hypothermia, run by University Hospital, Geneva at 16 sites in 9 countries.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Transient mild hypothermia (core body temperature 35-32°C) is common and usually without consequences for the brain or other organs. However, prolonged severe accidental hypothermia (core body temperature below 28°C) due to accidents is rare, and usually fatal in more than 50% of cases. Read more about this study

Who is it for?
Any ageHealthy volunteers can take part
Conditions the study is for
Accidental Hypothermia
What is being tested?
Registry of patients with accidental hypothermia
How many people
500 participants
Where
16 sitesin 9 countries
Study dates
1 Oct 2008to Dec 2054
How long will I take part?
1 Year
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Study population: The investigators aim to include patients of any age.

Who may be able to join

  • Accidental hypothermia with body core temperatures equal or less than 35°C/95°F;
  • Any cause leading to accidental hypothermia (e.g. mountain, water, urban);
  • Any age, gender, or comorbidities;
  • Any pre-hospital and hospital treatment and rewarming;
  • Any outcome.

Who cannot join

  • Patient opposition to be part of a study;
  • Essential missing values, e.g. temperature.

Trial locations and contacts

16 sites in 9 countries. Contact the study team or a site near you to ask about taking part.

Evelien Cools, MD contact

+41774191851

Evelien.Cools@hcuge.ch

Beat Walpoth, PD contact

+41793300900

Beat.Walpoth@unige.ch

16 sites in 9 countries

Switzerland4 sites, 4 recruiting
  • Kantonsspital Chür

    Chur

    Frank Hillgärtner, MD, +41 81 256 61 11, frank.hillgaertner@ksgr.ch

    Recruiting
  • Division of Anaesthesiology

    Geneva

    Evelien Cools, MD, 0041774191851, Evelien.Cools@hcuge.ch

    Delphine Courvoisier, PD

    Recruiting
  • Osepedale Regionale di Lugano

    Lugano

    Alessandro Chiesa, MD, 0918116111, Alessandro.Chiesa2@eoc.ch

    Recruiting
  • University Hospital Zürich

    Zurich

    Matthias Hilty, PD, 044 255 11 11, Matthias.Hilty@usz.ch

    Recruiting

Other trials in Switzerland

Italy3 sites, 2 recruiting
  • ASST Bergamo Est

    Bergamo

    Filippo Manelli, +39 035 306 1111, f.manelli68@gmail.com

    Recruiting
  • EURAC Research

    Bolzano

    Simon Rauch, PD, +39 0471 055055, simon.rauch@eurac.edu

    Recruiting
  • Ospedale Santa Chiara

    Trento

    Active, not recruiting

Other trials in Italy

Austria2 sites, 2 recruiting
  • Medical University Innsbruck

    Innsbruck

    Peter Mair, PD, +43 512 90030, p.mair@tirol-kliniken.at

    Recruiting
  • Krankenhaus Barmherzige Brüder

    Salzburg

    Peter Paal, PD, +4251250480448, Peter.Paal@icloud.com

    Recruiting

Other trials in Austria

Spain2 sites, 2 recruiting
  • Vall d'Hebron University Hospital

    Barcelona

    Robert Blasco, MD, +34 934 89 30 00, roblasc.rb@gmail.com

    Recruiting
  • Hospital de Cerdanya

    Girona

    Inigo Soteras, +34 972 65 77 77, inigosoteras@yahoo.es

    Recruiting

Other trials in Spain

Denmark1 site, 1 recruiting
  • Rigshospitalet

    Copenhagen

    Michael Wanscher, +45 35 45 35 45, micheal.wanscher@rh.regionh.dk

    Recruiting

Other trials in Denmark

Germany1 site
  • Klinik Immenstadt

    Immenstadt im Allgäu

    Active, not recruiting

Other trials in Germany

Japan1 site, 1 recruiting
  • Hokkaido Ohno Memorial Hospital

    Hokkaido

    Kazue Oshiro, MD, +81 11-665-0020, kazooshiro@gmail.com

    Recruiting

Other trials in Japan

Poland1 site, 1 recruiting
  • Medical University of Silesia

    Katowice

    Tomasz Darocha, +48 32 208 36 00, tomekdarocha@wp.pl

    Recruiting

Other trials in Poland

United Kingdom1 site
  • University of Portsmouth

    Portsmouth

    Active, not recruiting

Other trials in United Kingdom

About this study

Official title: International Hypothermia Registry: a Registry With Worldwide Cases of Accidental Hypothermia

Transient mild hypothermia (core body temperature 35-32°C) is common and usually without consequences for the brain or other organs. However, prolonged severe accidental hypothermia (core body temperature below 28°C) due to accidents is rare, and usually fatal in more than 50% of cases. Little is known on its physiopathology, on prognostic factors for rewarming decision or ideal rewarming techniques for better survival. Furthermore, complications after successful rewarming are extremely frequent and very often severe or fatal.

Accidental hypothermia is a frequent problem during the winter months and can be caused by snow sport accidents, near drowning and urban cold exposure. The International Hypothermia Registry's principle goal is to increase knowledge on accidental hypothermia by creating the largest database on accidental hypothermia which will comprise enough patient data to give a statistical power since the causes of accidental hypothermia and its treatment varies greatly.

The International Hypothermia Registry (IHR) will enable improvement of pre- and in-hospital treatment and rewarming methods, study survival predictors and prevention of post-rewarming complications. By this way, the IHR will permit the establishment of evidence-based diagnosis and treatment guidelines.

Read the detailed description

The aim of the International Hypothermia Registry is to improve rescue, treatment and outcome of accidental hypothermia victims.

The principal objectives of the International Hypothermia Registry are:

  • Improving the outcome of accidental hypothermic patients (survival and normal neurologic function);
  • This outcome is dependent on the presenting status of the patient (temperature, trauma, cardiac arrest, etc.);
  • The hospital treatment and rewarming method will also influence the outcome, invasive vs. non-invasive rewarming and rewarming rate.
  • Quality control, assessment of hypothermia cases

This IHR is mainly prospective but retrospective entries are welcome.

There is no data limit on retrospective cases: cases of any year can be entered.

Being tested
Registry of patients with accidental hypothermia
Keywords
Accidental Hypothermia
Medical subject headings
Hypothermia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Registry of patients with accidental hypothermiaOther

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The Registry is a questionnaire, containing 252 variables divided into a demographical, prehospital, hospital and outcome section. The collected measurement data will be registered on REDCap.

    For every patient, the questionnaire on REDCap will be filled in. Demographical data contain age, weight, consent status, ... . Prehospital data include the prehospital temperature, the circumstances of the accident (drowning, avalanche, intoxication, ... ), the presence of cardiac arrest, the first heart rhythm, ... . Hospital data contain the rewarming mode, the complications after and during rewarming. Outcome data cover the cerebral performance category after hospitalisation.

    Every further study with their specific outcomes using the data of the International Hypothermia Registry will be registered separately on clinical trials.gov. The data that are necessary to answer the scientific question defined in further studies will be extracted from REDCap.

    Measured: through study completion, an average of 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Jan 2024
  2. Study start1 Oct 2008
  3. Primary completionJul 2020
  4. Study completionDec 2054 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Other
Enrolment
500 participants (estimated)
Target duration
1 Year
IDs, dates and publications
ClinicalTrials.gov ID
NCT06200285
Sponsor's protocol ID
2022-02000
Acronym
IHR
Status last verified
Dec 2023
First submitted
12 Nov 2023
Last updated
11 Jan 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Accidental Hypothermia, run by University Hospital, Geneva at 16 sites in 9 countries.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 11 Jan 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 16 sites in Switzerland, Italy, Austria, Spain, Denmark and 4 more countries. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Evelien Cools, MD (+41774191851, Evelien.Cools@hcuge.ch), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The Registry is a questionnaire, containing 252 variables divided into a demographical, prehospital, hospital and outcome section. The collected measurement data will be registered on REDCap. (time frame: through study completion, an average of 1 year). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Jan 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in